Gu XY - Search Results

1

TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers.

Zheng QX, Wang J, Gu XY, Huang CH, Chen C, Hong M, Chen Z. Zheng QX, et al. Among authors: gu xy. Biomed Pharmacother. 2021 Mar;135:111169. doi: 10.1016/j.biopha.2020.111169. Epub 2021 Feb 1. Biomed Pharmacother. 2021. PMID: 33433359 Free article. Review.

2

Immune checkpoint targeting TIGIT in hepatocellular carcinoma.

Zheng Q, Xu J, Gu X, Wu F, Deng J, Cai X, Wang G, Li G, Chen Z. Zheng Q, et al. Am J Transl Res. 2020 Jul 15;12(7):3212-3224. eCollection 2020. Am J Transl Res. 2020. PMID: 32774695 Free PMC article. Review.

3

Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes.

Gu X, Guan J, Xu J, Zheng Q, Chen C, Yang Q, Huang C, Wang G, Zhou H, Chen Z, Zhu H. Gu X, et al. J Transl Med. 2021 Jan 6;19(1):26. doi: 10.1186/s12967-020-02691-4. J Transl Med. 2021. PMID: 33407546 Free PMC article.

4

The dual functions of the long noncoding RNA CASC15 in malignancy.

Gu X, Chu Q, Zheng Q, Wang J, Zhu H. Gu X, et al. Biomed Pharmacother. 2021 Mar;135:111212. doi: 10.1016/j.biopha.2020.111212. Epub 2021 Feb 1. Biomed Pharmacother. 2021. PMID: 33433353 Free article. Review.

5

Natural Killer T Cells in Various Mouse Models of Hepatitis.

Guan J, Wang G, Yang Q, Chen C, Deng J, Gu X, Zhu H. Guan J, et al. Biomed Res Int. 2021 Jan 6;2021:1782765. doi: 10.1155/2021/1782765. eCollection 2021. Biomed Res Int. 2021. PMID: 33506011 Free PMC article. Review.

6

HAND2-AS1: A functional cancer-related long non-coding RNA.

Gu X, Zheng Q, Chu Q, Zhu H. Gu X, et al. Biomed Pharmacother. 2021 May;137:111317. doi: 10.1016/j.biopha.2021.111317. Epub 2021 Feb 5. Biomed Pharmacother. 2021. PMID: 33556872 Free article. Review.

7

DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression.

Zheng Q, Gu X, Yang Q, Chu Q, Dai Y, Chen Z. Zheng Q, et al. Clin Chim Acta. 2021 Jun;517:1-8. doi: 10.1016/j.cca.2021.02.006. Epub 2021 Feb 17. Clin Chim Acta. 2021. PMID: 33607068 Review.

8

Transcription factor E2F4 is an indicator of poor prognosis and is related to immune infiltration in hepatocellular carcinoma.

Zheng Q, Fu Q, Xu J, Gu X, Zhou H, Zhi C. Zheng Q, et al. J Cancer. 2021 Jan 21;12(6):1792-1803. doi: 10.7150/jca.51616. eCollection 2021. J Cancer. 2021. PMID: 33613768 Free PMC article.

9

Factors associated with a SARS-CoV-2 recurrence after hospital discharge among patients with COVID-19: systematic review and meta-analysis.

Yao MQ, Zheng QX, Xu J, Deng JW, Ge TT, Zhou HB, Wu FT, Gu XY, Yang Q, Ren YL, Wang G, Chen Z. Yao MQ, et al. Among authors: gu xy. J Zhejiang Univ Sci B. 2020 Dec.;21(12):940-947. doi: 10.1631/jzus.B2000304. J Zhejiang Univ Sci B. 2020. PMID: 33843159 Free PMC article.

10

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions.

Zheng Q, Yang Q, Zhou J, Gu X, Zhou H, Dong X, Zhu H, Chen Z. Zheng Q, et al. Cancer Cell Int. 2021 Jun 30;21(1):330. doi: 10.1186/s12935-021-02033-4. Cancer Cell Int. 2021. PMID: 34193146 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters